Literature DB >> 8788533

Hippocampal 5-HT1A receptor binding site densities, 5-HT1A receptor messenger ribonucleic acid abundance and serotonin levels parallel the activity of the hypothalamo-pituitary-adrenal axis in rats.

P W Burnet1, I N Mefford, C C Smith, P W Gold, E M Sternberg.   

Abstract

We have previously demonstrated that susceptibility of the Lewis rat to inflammatory disease, compared to the relatively resistant Fischer F344 rat, is related to a hyporesponsive hypothalamopituitary adrenal axis to inflammatory and other stress mediators. Since 5-HT and the 5HT1A receptor are important stimulators of this axis, we have investigated the levels of 5-HT1A receptor binding sites and encoding mRNA, 5-HT and 5-hydroxyindole acetic acid in various brain regions of Lewis, Harlan Sprague Dawley and Fischer F344 rats. Lewis rats expressed significantly less hippocampal and frontal cortical 5-HT1A receptor binding sites and mRNA than Harlan Sprague-Dawley and Fischer F344 rats. Adrenalectomy increased the number of 5HT1A receptor binding sites and mRNA expression in the hippocampus of all three strains. The levels of hippocampal 5-HT in Fischer F344 rats were significantly greater than levels detected in the same regions for the other two strains. Hypothalamic 5-HT and 5-hydroxyindole acetic acid levels in Harlan Sprague-Dawley rats were higher than the same area from the other two strains. Adrenalectomy increased the levels of 5-hydroxyindole acetic acid in the hypothalamus of all three strains. We conclude that hippocampal 5-HT1A receptor densities and 5-HT levels in the rat parallel the the activity and responsiveness of the hypthalamopituitary-adrenal axis. We have published these data in an earlier report.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8788533     DOI: 10.1016/0166-4328(96)00116-7

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  9 in total

1.  Effects of clomipramine on self-control choice in Lewis and Fischer 344 rats.

Authors:  Karen G Anderson; William L Woolverton
Journal:  Pharmacol Biochem Behav       Date:  2005-01-18       Impact factor: 3.533

2.  Steady-state assessment of impulsive choice in Lewis and Fischer 344 rats: between-condition delay manipulations.

Authors:  Gregory J Madden; Nathaniel G Smith; Adam T Brewer; Jonathan W Pinkston; Patrick S Johnson
Journal:  J Exp Anal Behav       Date:  2008-11       Impact factor: 2.468

3.  Comparison of female Fischer and Sprague-Dawley rats in the response to ketanserin.

Authors:  Chandra Suma Johnson Miryala; Cindy Hiegel; Lynda Uphouse
Journal:  Pharmacol Biochem Behav       Date:  2013-11-04       Impact factor: 3.533

4.  A long-term study of the impulsive choices of Lewis and Fischer 344 rats.

Authors:  Carlos F Aparicio; Mirari Elcoro; Benigno Alonso-Alvarez
Journal:  Learn Behav       Date:  2015-09       Impact factor: 1.986

5.  Dose-dependent effects of the antiprogestin, RU486, on sexual behavior of naturally cycling Fischer rats.

Authors:  Lynda Uphouse
Journal:  Behav Brain Res       Date:  2015-01-12       Impact factor: 3.332

6.  Effects of acute and repeated nicotine administration on delay discounting in Lewis and Fischer 344 rats.

Authors:  Karen G Anderson; James W Diller
Journal:  Behav Pharmacol       Date:  2010-12       Impact factor: 2.293

7.  Effects of prenatal ethanol exposure on regulation of basal hypothalamic-pituitary-adrenal activity and hippocampal 5-HT1A receptor mRNA levels in female rats across the estrous cycle.

Authors:  J H Sliwowska; N Lan; F Yamashita; A G Halpert; V Viau; J Weinberg
Journal:  Psychoneuroendocrinology       Date:  2008-07-30       Impact factor: 4.905

8.  Modest effects of repeated fluoxetine on estrous cyclicity and sexual behavior in Sprague Dawley female rats.

Authors:  Navin Maswood; Jhimly Sarkar; Lynda Uphouse
Journal:  Brain Res       Date:  2008-10-02       Impact factor: 3.252

Review 9.  Fischer 344 and Lewis Rat Strains as a Model of Genetic Vulnerability to Drug Addiction.

Authors:  Cristina Cadoni
Journal:  Front Neurosci       Date:  2016-02-09       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.